Dyne Therapeutics, Inc.

Nasdaq:DYN

Pharmaceutical Preparations·WALTHAM, MA

The dyne is a derived unit of force specified in the centimetre–gram–second (CGS) system of units, a predecessor of the modern SI.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/2/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	7/28/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

25 shown

Filed	Period
3/2/26	Q1 FY2026	→
1/12/26	Q4 FY2026	→
11/5/25	Q4 FY2025	→
7/28/25	Q2 FY2025	→
5/8/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
↓

News (8-K)

31 shown

Filed	Type	Description
12/23/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/10/25	Agreement	Entry into a Material Definitive Agreement	→
12/8/25	New Debt	Creation of a Direct Financial Obligation	→
12/8/25	Reg FD	Regulation FD Disclosure	→
10/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/4/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

31 shown

Filed	Form	Description
3/2/26	S-8	S-8	→
12/10/25	424B5	424B5	→
12/8/25	424B5	424B5	→
7/1/25	424B5	424B5	→
6/30/25	424B5	424B5	→
4/15/25	ARS	ARS	→
↓

Filing History(636 filings)

TypeDateAccessionPeriodSize

144

Mar 9, 2026

0001969223-26-000322

—

4.4 KB

Mar 6, 2026

0001193125-26-0965234

Mar 5, 2026

5.0 KB

Mar 6, 2026

0001193125-26-0965174

Mar 5, 2026

4.9 KB

Mar 6, 2026

0001193125-26-0965124

Mar 5, 2026

7.9 KB

SCHEDULE 13G/A

Mar 6, 2026

0001897612-26-000307

—

7.3 KB

144

Mar 5, 2026

0001972481-26-000086

—

4.7 KB

S-8

Mar 2, 2026

0001193125-26-084245S-8

—

649.2 KB

8-K

Mar 2, 2026

0001193125-26-0842078-K

Mar 2, 2026

351.0 KB

10-K

Mar 2, 2026

0001193125-26-08417810-K

Dec 31, 2025

18.5 MB

Feb 17, 2026

0001193125-26-0550754

Feb 12, 2026

9.9 KB

Feb 17, 2026

0001193125-26-0550704

Feb 12, 2026

7.0 KB

Feb 17, 2026

0001193125-26-0550634

Feb 12, 2026

7.0 KB

Feb 17, 2026

0001193125-26-0550524

Feb 12, 2026

6.9 KB

SCHEDULE 13G/A

Feb 17, 2026

0001274173-26-000088

—

11.6 KB

8-K

Jan 12, 2026

0001193125-26-0097828-K

Jan 12, 2026

15.7 MB

SCHEDULE 13G

Jan 8, 2026

0001897612-26-000009

—

7.1 KB

Dec 23, 2025

0001193125-25-3308634

Dec 22, 2025

5.0 KB

Dec 23, 2025

0001193125-25-3308413

Dec 22, 2025

13.0 KB

8-K

Dec 23, 2025

0001193125-25-3295118-K

Dec 22, 2025

163.6 KB

424B5

Dec 10, 2025

0001193125-25-314307424B5

—

669.2 KB

8-K

Dec 10, 2025

0001193125-25-3142498-K

Dec 9, 2025

463.4 KB

424B5

Dec 8, 2025

0001193125-25-311254424B5

—

531.4 KB

8-K

Dec 8, 2025

0001193125-25-3112218-K

Dec 8, 2025

132.3 KB

8-K

Dec 8, 2025

0001193125-25-3105168-K

Dec 8, 2025

14.3 MB

144

Dec 5, 2025

0001972481-25-000298

—

5.2 KB

25 filings shown

Filed	Form	Description
4/15/25	DEFA14A	DEFA14A	→
4/15/25	DEF 14A	DEF 14A	→
4/5/24	DEFA14A	DEFA14A	→
4/5/24	DEF 14A	DEF 14A	→
4/7/23	DEFA14A	DEFA14A	→
4/7/23	DEF 14A	DEF 14A	→
↓

Dyne Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(636 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	4	4	→
3/6/26	4	4	→
3/6/26	4	4	→
2/17/26	4	4	→
2/17/26	4	4	→
2/17/26	4	4	→
↓

Filed	Form	Description
3/9/26	144	144	→
3/6/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/5/26	144	144	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/8/26	SCHEDULE 13G	SCHEDULE 13G	→
12/5/25	144	144	→
↓